Citigroup’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Citigroup's OGN Position: Q2 2026 in Review
Citigroup reduced its Organon & Co (OGN) stake by 34% in Q2 2026, selling an estimated $2.45M and leaving 392,268 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.
Citigroup first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $18.2M in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Citigroup held 392,268 shares of Organon & Co worth $5.31M as of Q2 2026.
- Citigroup sold 204,504 Organon & Co shares in Q2 2026, an estimated $2.45M.
- Organon & Co made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2096 holding.
- Citigroup first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Citigroup's Organon & Co position peaked at $18.2M in Q2 2021.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.